2025-07-29

SAGA Diagnostics Announces Medicare Coverage for Pathlight MRD Test in Breast Cancer
2025-06-25

Navinci Secures €5.3 Million in Funding from Existing Owners and a Strategic Investment from Jonathan Milner at Meltwind
2025-04-25

Basic Genomics Closes SEK 11.7M Investment Round to Support RNA Analysis Tech
2025-02-18

Susanna Francke Rodau as the new CEO of SMA
2024-11-18

Quanta Dialysis Secures New Funding
2024-11-04

Quanta Dialysis Technologies Receives FDA Clearance for Home Dialysis System
2024-10-24

Jenny Sundqvist appointed CEO of Navinci
2024-09-06

CytaCoat and Absorbest announce development and licensing agreement for superabsorbent advanced wound care dressings
2023-09-28

Segulah Medical Acceleration announces investment in Senzime
2023-08-28

Collective Minds Radiology announces closing of SEK 84m financing, led by Segulah Medical Acceleration and existing shareholders
2023-02-20

Navinci appoints Eva Pisa as chairman, further strengthens the leadership team and establishes a Scientific Advisory Board
2023-02-16

Allurion to Go Public on NYSE
2022-09-13

Segulah Medical Acceleration Announces Investment in Allurion Technologies
2022-07-12

Segulah Medical Acceleration Announces Investment in Navinci Diagnostics
2022-02-28

Signifier Medical Technologies is granted HCPCS Codes
2021-07-30

Segulah Medical Acceleration Announces Investment in Signifier Medical Technologies
2021-06-30

Segulah Medical Acceleration Announces Investment in SAGA Diagnostics
2021-06-28

Segulah Medical Acceleration Announces Investment in Quanta Dialysis Technologies
2021-04-29

Blue chip investors back new MedTech investment company